ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
Author(s): Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ
Source: CLINICAL INFECTIOUS DISEASES    Volume: 34    Issue: 1    Pages: 7-14    Published: JAN 1 2002  
Times Cited: 1,039     References: 35     
Abstract: During the past several decades, there has been a steady increase in the frequency of opportunistic invasive fungal infections (IFIs) in immunocompromised patients. However, there is substantial controversy concerning optimal diagnostic criteria for these IFIs. Therefore, members of the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group formed a consensus committee to develop standard definitions for IFIs for clinical research. On the basis of a review of literature and an international consensus, a set of research-oriented definitions for the IFIs most often seen and studied in immunocompromised patients with cancer is proposed. Three levels of probability are proposed: "proven," "probable," and "possible." The definitions are intended for use in the context of clinical and/or epidemiological research, not for clinical decision making.
Document Type: Article
Language: English
Reprint Address: Walsh, TJ (reprint author), NCI, 9000 Rockville Pike,Bldg 10,Rm 13N240, Bethesda, MD 20892 USA
Addresses:
1. European Org Res Treatment Canc, Invas Infect Cooperat Grp, Brussels, Belgium
2. NIAID, Mycoses Study Grp, NIH, Bethesda, MD 20892 USA
Publisher: UNIV CHICAGO PRESS, 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
Subject Category: Immunology; Infectious Diseases; Microbiology
IDS Number: 498ZM
ISSN: 1058-4838
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo